Santen Pharmaceutical Co Ltd

Compare

0 Followers

4536 Stock Chart & Stats

¥1495.00

-¥11.50(-0.71%)

At close: Jan 08 4:00 PM EST

¥1495.00

-¥11.50(-0.71%)

Day’s Range― - ―

52-Week Range¥1,310.50 - ¥1,833.00

Previous CloseN/A

Volume1.29M

Average Volume (3M)1.30M

Market Cap

$513.49B

Enterprise Value¥511.86B

Total Cash (Recent Filing)$93.00B

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)16.4

Beta0.38

Next Earnings

Nov 06, 2025

EPS Estimate

20.89

Last Dividend Ex-Date

Sep 29, 2025

Dividend Yield2.59%

Share Statistics

EPS (TTM)17.32

Shares Outstanding342,068,540

10 Day Avg. Volume1,416,570

30 Day Avg. Volume1,302,203

Financial Highlights & Ratios

PEG Ratio0.32

Price to Book (P/B)1.73

Price to Sales (P/S)1.65

P/FCF Ratio9.11

Enterprise Value/Market Cap1.00

Enterprise Value/Revenue1.71

Enterprise Value/Gross Profit3.08

Enterprise Value/Ebitda7.52

Forecast

1Y Price Target

$2,153.23

Price Target Upside44.03% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

Santen Pharmaceutical Co News

Santen Completes Disposal of Treasury Shares for Stock Remuneration Plan

An announcement from Santen Pharmaceutical Co ( ($JP:4536) ) is now available. Santen Pharmaceutical Co., Ltd. has completed...

16h ago

Santen Pharmaceutical Announces Disposal of Treasury Shares for Stock Remuneration Plan

Santen Pharmaceutical Co ( ($JP:4536) ) has issued an announcement. Santen Pharmaceutical Co., Ltd. has announced the disposal...

1M ago

Santen Pharmaceutical Reports Progress on Share Buyback Initiative

Santen Pharmaceutical Co ( ($JP:4536) ) has shared an announcement. Santen Pharmaceutical Co., Ltd. announced the status of...

1M ago

Santen Pharmaceutical Suspends Treasury Share Disposal Plan

The latest update is out from Santen Pharmaceutical Co ( ($JP:4536) ). Santen Pharmaceutical Co. has announced the...

1M ago

Santen Pharmaceutical Announces Treasury Share Disposal for Performance-linked Remuneration

Santen Pharmaceutical Co ( ($JP:4536) ) has issued an update. Santen Pharmaceutical Co., Ltd. has announced the disposal...

2M ago

Santen Pharmaceutical Updates on Share Buyback Progress

Santen Pharmaceutical Co ( ($JP:4536) ) just unveiled an update. Santen Pharmaceutical Co., Ltd. announced the status of...

2M ago

Santen Pharmaceutical Reports Decline in Q2 2025 Financials; Maintains Dividend Forecasts

Santen Pharmaceutical Co ( ($JP:4536) ) has shared an announcement. Santen Pharmaceutical Co. reported a decline in its...

3M ago

Santen Pharmaceutical Updates on Share Buyback Progress

Santen Pharmaceutical Co ( ($JP:4536) ) has issued an update. Santen Pharmaceutical Co., Ltd. announced the status of...

3M ago

Santen Pharmaceutical Updates on Share Buyback Progress

The latest update is out from Santen Pharmaceutical Co ( ($JP:4536) ). Santen Pharmaceutical Co., Ltd. announced the...

4M ago

Santen Pharmaceutical Announces Progress in Share Buyback Program

Santen Pharmaceutical Co ( ($JP:4536) ) has provided an announcement. Santen Pharmaceutical Co., Ltd. announced the status of...

5M ago

Clearside Biomedical’s partner signed new collaboration agreement with Santen

Clearside Biomedical (CLSD) announced today that the Company’s Asia-Pacific partner, Arctic Vision, has signed a new commercial collaboration...

12M ago

CLSD

Ocular Therapeutix appoints Graves to board of directors

Ocular Therapeutix (OCUL) announced the appointment of Adrienne Graves, Ph.D., to its Board of Directors. As the former...

2y ago

OCUL

4536 FAQ

What was Santen Pharmaceutical Co Ltd’s price range in the past 12 months?

Santen Pharmaceutical Co Ltd lowest stock price was ¥1310.50 and its highest was ¥1833.00 in the past 12 months.

What is Santen Pharmaceutical Co Ltd’s market cap?

Santen Pharmaceutical Co Ltd’s market cap is $513.49B.

When is Santen Pharmaceutical Co Ltd’s upcoming earnings report date?

Santen Pharmaceutical Co Ltd’s upcoming earnings report date is Nov 06, 2025 which is in 5 days.

How were Santen Pharmaceutical Co Ltd’s earnings last quarter?

Santen Pharmaceutical Co Ltd released its earnings results on Aug 07, 2025. The company reported ¥17.32 earnings per share for the quarter, missing the consensus estimate of ¥23.904 by -¥6.584.

Is Santen Pharmaceutical Co Ltd overvalued?

According to Wall Street analysts Santen Pharmaceutical Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Santen Pharmaceutical Co Ltd pay dividends?

Santen Pharmaceutical Co Ltd pays a Semiannually dividend of ¥19 which represents an annual dividend yield of 2.59%. See more information on Santen Pharmaceutical Co Ltd dividends here

What is Santen Pharmaceutical Co Ltd’s EPS estimate?

Santen Pharmaceutical Co Ltd’s EPS estimate is 20.89.

How many shares outstanding does Santen Pharmaceutical Co Ltd have?

Santen Pharmaceutical Co Ltd has 342,068,540 shares outstanding.

What happened to Santen Pharmaceutical Co Ltd’s price movement after its last earnings report?

Santen Pharmaceutical Co Ltd reported an EPS of ¥17.32 in its last earnings report, missing expectations of ¥23.904. Following the earnings report the stock price went up 0.241%.

Which hedge fund is a major shareholder of Santen Pharmaceutical Co Ltd?

Currently, no hedge funds are holding shares in JP:4536

Company Description

Santen Pharmaceutical Co Ltd

Santen Pharmaceutical Co., Ltd. (Ticker: 4536) is a global pharmaceutical company headquartered in Japan, specializing in the research, development, manufacturing, and marketing of products primarily for ophthalmology. Established in 1890, Santen focuses on innovative treatments for various eye diseases and conditions, including glaucoma, retinal disorders, and dry eye disease. The company operates in multiple sectors, including prescription pharmaceuticals, over-the-counter (OTC) products, and medical devices, aiming to improve the quality of life for patients worldwide.

Santen Pharmaceutical Co (4536) Earnings & Revenues

Historic Earnings Reports

4536 Stock 12 Month Forecast

Average Price Target

¥2,153.23

▲(44.03% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1338":"¥1,338","2585":"¥2,585","1649.75":"¥1,649.8","1961.5":"¥1,961.5","2273.25":"¥2,273.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2584.493041715,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥2.58K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2153.234439488,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.15K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1689.8608349675,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥1.69K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1338,1649.75,1961.5,2273.25,2585],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2021","6":"Jul<br/>2024","9":"Apr<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1642,1714.4994647473077,1786.9989294946154,1859.498394241923,1931.9978589892307,2004.4973237365384,2076.996788483846,2149.496253231154,2221.9957179784615,2294.495182725769,2366.994647473077,2439.4941122203845,2511.993576967692,{"y":2584.493041715,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1642,1681.3257261144615,1720.651452228923,1759.9771783433846,1799.3029044578461,1838.6286305723077,1877.9543566867692,1917.280082801231,1956.6058089156923,1995.931535030154,2035.2572611446153,2074.582987259077,2113.9087133735384,{"y":2153.234439488,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1642,1645.6816026898077,1649.3632053796155,1653.0448080694232,1656.7264107592307,1660.4080134490384,1664.0896161388462,1667.771218828654,1671.4528215184616,1675.1344242082694,1678.8160268980769,1682.4976295878846,1686.1792322776923,{"y":1689.8608349675,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1339.914,"date":1612137600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1339.914,"date":1614556800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1339.914,"date":1617235200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1339.914,"date":1617235200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1339.914,"date":1625097600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1354.244,"date":1627776000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1600.788,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1710.954,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1528.021,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1410.417,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1594.749,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1652.57,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1642,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >